U.S. stocks rebounded on Tuesday, July 21, 2026, after Monday’s risk-off tone, with futures and sentiment improving as investors leaned into earnings strength and a modest easing in some geopolitical pressure. The best read for today is a “rotation-within-risk” tape: cyclicals and…
Sable Offshore Corp. (NYSE: SOC) and Similarweb Ltd. (NYSE: SMWB) add two very different—but highly instructive—chapters to the evolving energy and data narrative already being written by Vivakor Inc. (NASDAQ: VIVK), Exxon Mobil Corporation (NYSE: XOM) and Shell plc (NYSE: SHEL).
Offshore…
Hollywood just added a new kind of tentpole: the AI post‑production startup. Investors would be wise to pay attention, because behind the celebrity headlines around Ben Affleck’s InterPositive sale to Netflix sits an emerging stack that runs straight through NVIDIA (NVDA) and…
Sable Offshore Corp. (NYSE: SOC) is one of the market’s most combustible stories: a small-cap oil name with real production upside, serious legal overhangs, and enough headline voltage to keep traders awake and counsel employed. The investment case is not subtle, but…
Doximity Inc. (NYSE:DOCS) is quietly building one of Wall Street’s more compelling healthcare-tech narratives: a profitable, AI‑infused digital platform for U.S. clinicians that is leaning into clinical AI, telehealth, and value‑based care just as the medical establishment starts asking for them in…
Eli Lilly and Company’s (NYSE: LLY) recent equity investment in ŌURA Health and the Oura Ring ecosystem, paired with Modular Medical’s (NASDAQ: MODD) launch of its Pivot tubeless insulin patch pump, is giving Wall Street a preview of what next‑generation metabolic care…
Jerry Seinfeld has built the kind of real estate-and-collector-car portfolio that makes developers, auction houses, and REIT analysts all reach for a second espresso—and Hudson Pacific Properties, Inc. (NYSE: HPP) would likely approve of the playbook.
The Asset Class Behind The Laughs…
US equities traded somewhat mixed to lower on Monday, July 20, 2026, as investors balanced rising oil prices, an AI-led factor rotation, and mounting anticipation around upcoming Big Tech earnings. The S&P 500 slipped modestly while the Dow underperformed and the Nasdaq…
Eupraxia Pharmaceuticals, Inc. (NASDAQ: EPRX) is quietly setting up one of the more intriguing biotech inflection points on Wall Street as it marches toward Phase 2b data for EP‑104GI in eosinophilic esophagitis (EoE) this December, with investors increasingly framing the “bar” in…
Wall Street has finally found something that can make even the most swaggering AI GPU look nervous: the memory wall. The very chips designed to feed artificial intelligence its endless diet of data are hitting physical, economic, and manufacturing limits—and the result…
